

Old Reactors Lead to Supply Chain Disruptions for Cancer Diagnosis
The breakdown of a Belgian nuclear reactor producing radionuclides used in cancer diagnosis is creating global supply chain disruptions.
The breakdown of a Belgian nuclear reactor producing radionuclides used in cancer diagnosis is creating global supply chain disruptions.
A group of nine countries, including the Netherlands, Sweden, Belgium and Denmark, already warned the EU that it was going too far.
Germany and Poland are the countries facing the greatest likelihood of suffering from a coal shortfall.
The EU wants to reduce its dependence on imported semiconductors and has announced a new major spending programme: the so-called “Chips Act.”